Conference - London, United Kingdom
Oxford Global’s 3rd Annual Biosimilars & Biobetters Congress is bringing together over 350 senior-level key opinion leaders working in the biologics sector.
The conference program consists of two days:
• Day 1 – Market Access Strategies, Opportunities And Commercial Challenges
• Day 2 – Developing Biosimilars And Biobetters
• Day 2 – Developing Biosimilars And Biobetters
On day one delegates will hear presentations about the latest regulatory updates, global commercialisation strategies and biosimilars challenges & opportunities in emerging markets from representatives of Pfizer, Merck Serono and Baxter.
Day two will focus on case studies demonstrating biosimilarity, overview of the insulin biosimilar market and the future of biosimilar and biobetter development. Delegates will meet representatives from well-known pharma companies such as Boehringer Ingelheim, MedImmune, Teva, Sanofi and many more.
The Biosimilars Congress is co-located with our 8th Annual Proteins & Antibodies and 2nd Annual Peptides Congress.
- Organization: Oxford Global Conferences
Mon, Apr 20, 2015 - Tue, Apr 21, 2015
Novotel London West
1 Shortlands, Hammersmith International Ctre, London, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
